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Primate lentiviruses encode for an unique nef gene with an essential function in both viral replication and pathogenicity in
the host. The molecular basis for this function remains however poorly defined. Several Nef-binding cellular proteins are
thought to be instrumental in its function. Indeed, Nef contains a proline-rich motif implicated in the binding to the Src-like
tyrosine kinase Hck and also to a Ser/Thr kinase of molecular weight 62 kDa. The disruption of this motif affects the binding
to both these kinases as well as viral replication. Whereas Hck is expressed in the myeloid lineage and hence may account
for the nef function in infected monocytes, we and others have reported previously that Nef also interacts with the
T-lymphocyte Src-kinase Lck, leading to specific cell signaling impairment. This interaction occurs through the binding of Nef
to both Lck SH2 and SH3 domains. Both the proline motif and phosphorylation of Nef on tyrosine residue were proposed to
account for these interactions. Here, we investigate the mechanism of Lck SH2 binding by HIV-1 Nef. Using recombinant
fusion proteins to precipitate lysates, we show that although SH2 binding is dependent on phosphorylation events, it occurs
in a tyrosine independent manner because it requires neither tyrosine residues in Nef nor the phosphotyrosine binding
pocket from the Lck SH2 domain, hence suggesting a role for a phosphoserine or a phosphothreonine residue. Further, we
show that Hck SH2 does not interact with Nef, indicating that Hck SH3 binding is sufficient for Nef binding, whereas Lck SH2
cooperates together with SH3 to allow Nef binding to a level similar to Hck SH3. Together, our results establish different
mechanisms for Hck and Lck binding by HIV-1 Nef protein, and identify a novel mechanism for Src-like tyrosine kinase
targeting by a viral protein. © 1998 Academic Press
INTRODUCTION
Besides genes encoding for structural proteins, the
genome of the primate lentiviruses (HIV-1, HIV-2, and SIV)
also encodes for proteins with essential function at dif-
ferent stages of the viral life cycle (Trono, 1995). One of
these, nef, expresses a myristoylated 25- to 34-kDa
membrane-associated protein (Franchini et al., 1986; Guy
et al., 1987). In the simian model of acquired immunode-
ficiency syndrome (AIDS), the nef gene is essential for
high virus titer replication and pathogenesis (Kestler et
al., 1991). The requirement of HIV-1 nef for in vivo repli-
cation and pathogenicity was similarly established in the
murine model of hu-SCID mice (Jamieson et al., 1994;
Aldrovandi and Zack, 1996; Gulizia et al., 1997). Further,
mice expressing a lymphoid targeted nef transgene de-
velop a sever T cell depletion with altered T cell func-
tions (Brady et al., 1993; Skowronski et al., 1993; Linde-
mann et al., 1994), which indicate that nef can affect both
viral and cellular functions. In vitro, nef enhances viral
replication (Miller et al., 1994; Spina et al., 1994) and
increases the infectivity of viral particles (Chowers et al.,
1994; Aiken and Trono, 1995). Nef also downregulates
cell-surface expression of CD4 and MHC class I through
increased endocytosis (Guy et al., 1987; Garcia and
Miller, 1991; Aiken et al., 1994; Schwartz et al., 1996) and
was found to regulate cell signaling (Baur et al., 1994;
Collette et al., 1996b; Iafrate et al., 1997), leading to a
specific impairment of cytokine production (Luria et al.,
1991; Collette et al., 1996a). While membrane-receptor
downregulation and viral replication promotion appear
independent functions of nef (Goldsmith et al., 1995;
Legall et al., 1997), a correlation was established be-
tween Nef-cellular protein kinases interaction and in-
crease in viral infectivity and replication (Goldsmith et al.,
1995; Saksela et al., 1995; Wiskerchen and Cheng, 1996;
Swingler et al., 1997). Nef was found to form complexes
with cellular kinases known for their essential function in
cell signaling, including a protein related to the family of
the p21-activated kinases (PAK) whose identity remains
to be formally defined (Cullen, 1996; Nunn and Marsh,
1996; Sawai et al., 1994, 1996), the serine/threonine ki-
nases MAPK/Erk2 (Greenway et al., 1995, 1996) and
PKCu (Smith et al., 1996), as well as members of the Src
family of tyrosine kinases: Hck and Lyn (Saksela et al.,
1995), Lck (Greenway et al., 1995; Collette et al., 1996b),
and Fyn (Greenway et al., 1995).
Src tyrosine kinases are involved in signaling path-
ways that modulate growth, differentiation, and mature
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cell function and have been implicated in tumorigenesis,
inherited immunodeficiencies as well as in viral dis-
eases (Notarangelo, 1996; Bolen and Brugge, 1997; Col-
lette and Olive, 1997; Messerschmitt et al., 1997). Lck and
Fyn are expressed in T lymphocytes and regulate thymo-
cyte development, induction of cytotoxicity, and induction
of interleukin-2 (IL-2) as well as T cell receptor (TcR),
interleukin-2 receptor and CD28 signaling (Rudd et al.,
1994; Howe and Weiss, 1995). Hck and Lyn have a tissue
distribution restricted to haemapoietic cells from the
monocyte-macrophage lineage and have been impli-
cated in phagocytosis, Fc receptor and integrin signal-
ing. In addition to the Src-homology (SH)-1 region, which
forms the catalytic domain, Src kinases share common
structural features and are formed by an N-terminal re-
gion which features modification by myristoylation
and/or palmitoylation involved in membrane targeting
followed by SH3 and SH2 domains. Both these domains
mediate protein–protein interactions and contribute to
substrate recruitment, subcellular localization, and reg-
ulation of kinase activity (Pawson, 1995). SH3 domains
bind target proteins through specific proline sequences
(Ren et al., 1993), while SH2 domains bind specific ty-
rosine-phosphorylated containing sequences (Songyang
et al., 1993).
Nef contains a proline motif (Pxx)4 with striking simi-
larities with Src-homology (SH)-3 binding motifs (Shu-
gars et al., 1993). This (Pxx)4 motif is well conserved in all
known primate lentiviruses (SIV and HIV-1 and -2), it
adopts a polyproline type II helix structure, and it binds
directly and specifically to recombinant proteins contain-
ing the SH3 domain from the Src kinases Hck, Fyn or Lck,
yet with different affinity (Lee et al., 1995; Saksela et al.,
1995; Collette et al., 1996b; Greenway et al., 1996). The
crystal structure determination of the core region of Nef
complexed with a Src family SH3 domain has reveal that
the Nef-SH3 interface implicates more than the (Pxx)4
motif and induces local rearrangements in the SH3 do-
main (Lee et al., 1996; Arold et al., 1997). Both in vitro and
in vivo data have demonstrated that the Nef protein can
modulate Lck (Collette et al., 1996b; Greenway et al.,
1996), and Hck (Briggs et al., 1997; Moarefi et al., 1997)
function, which implicates SH3 binding (Collette et al.,
1996b; Greenway et al., 1996; Briggs et al., 1997) and can
lead to fibroblast transformation upon coexpression with
Hck (Briggs et al., 1997). Disruption of the (Pxx)4 motif
also reduces viral replication and infectivity in vitro
(Goldsmith et al., 1995; Saksela et al., 1995; Wiskerchen
and Cheng, 1996).
Similarly, the Nef protein encoded by the SIVmac239
and pbj14 isolates were found to interact with Src in
transfected COS cells and to be phosphorylated on ty-
rosine residue(s) upon coexpression with Src (Du et al.,
1995). These SIV Nef proteins contain YxxL motif(s) in the
N-terminus which upon phosphorylation of the tyrosine
residue may represent a putative Src family SH2-binding
motif. Indeed, this motif was found to be phosphorylated
on tyrosine residues by Lck and to allow association with
ZAP-70, a T cell specific tyrosine kinase (Luo and Peter-
lin, 1997). Although HIV-1 Nef does not contain a similar
YxxL motif, we previously reported a weak phosphoryla-
tion of HIV-1 Nef on tyrosine residues (Collette et al.,
1996b). Furthermore, in addition to Lck SH3 binding, we
showed that cell-derived Nef can interact with Lck SH2
domain but not with other SH2 domains (Collette et al.,
1996b). SIV and HIV-1 Nef might thus have evolved an
additional binding motif to interact with Src family ty-
rosine kinases through SH2 binding.
Here, we investigate the mechanism of this interaction
of HIV-1 Nef protein with Lck SH2 domain. Using nef-
transfected cells, we show that Nef binds Lck but not
Hck SH2 domain and that this interaction compensate
the low affinity of Lck SH3, allowing an interaction of Nef
with Lck SH21SH3 similar to Hck SH3 binding efficiency.
Surprisingly, however, our results demonstrate that Nef
binds Lck SH2 through a novel mechanism depending
on phosphorylation events but which requires neither
tyrosine residues from Nef nor the phosphotyrosyl bind-
ing pocket from Lck SH2.
RESULTS
Differential Src-homology (SH)-domain binding usage
by HIV-1 Nef
To determine the region for binding to HIV-1 Nef, we
used Glutathione-S-Transferase recombinant protein
fused to SH2 and/or SH3 domains from Hck and Lck
tyrosine kinases as an affinity matrix to precipitate ly-
sates from the Jurkat lymphoblastoid T cell line tran-
siently transfected by a nef-containing plasmid. The pre-
cipitated proteins were analyzed by Nef Western blotting.
As shown in Fig. 1A, and following densitometric deter-
mination, the Hck SH3 recombinant protein allowed ef-
ficient precipitation of Nef from cell lysates (15% of total
amount of Nef present in cell lysates was precipitated by
Hck SH3), whereas the Lck SH3 was much less efficient
even at saturating doses (2%, Fig. 1B). The affinity for Nef
was, however, much increased when the Lck SH2 do-
main was added as an adjacent domain to Lck SH3,
allowing precipitation of Nef to a level similar to Hck SH3
(ranging from 10 to 16%). The Lck SH2 domain precipi-
tated Nef alone, even with unsaturating doses of recom-
binant proteins (Fig. 1B). Although Nef was precipitated
very efficiently by Hck SH3, it was not by Hck SH2 (Fig.
1C), despite comparable ability of Lck and Hck SH2
recombinant proteins to interact with phosphotyrosine
proteins (Fig. 1D).
We conclude from these results that Hck SH3 binding
was sufficient for Nef binding, whereas Lck SH2 coop-
erated together with SH3 to allow Nef binding at a level
similar to Hck SH3 alone. These results also extend
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FIG. 1. Src-homology (SH)-domain binding usage by HIV-1 Nef. Jurkat cells were transfected with pcDNA3-nef or mock transfected. Cell lysates (500
mg of total protein) were precipitated with GST recombinant protein containing the indicated Hck and Lck SH domain and analyzed by Western blot
for Nef binding (A, B, and C) or antiphosphotyrosine Western blotting (D). In (A, C, and D), 20 mg of recombinant GST were used, while in (B), increasing
amount were used ranging from 5 to 30 mg of GST recombinant proteins. Total lysates (TL) were included as controls (25 mg of total protein). Position
of molecular weight markers are indicated on the left in kDa.
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further the degree of specificity with which Nef interacts
with Src kinase SH2 domains (Collette et al., 1996b).
Characterization of Lck SH2:Nef interaction
To characterize the mechanism of Lck SH2 binding by
Nef, we next compared it with previously described Lck
SH2 substrates. Both Vav, the guanine nucleotide ex-
change factor for Rho-related proteins, and ZAP-70, a
tyrosine kinase thought to play a critical role in T-cell
receptor signal transduction, were efficiently precipitated
from cell lysates using the Lck SH2 recombinant proteins
(Fig. 2A). Similarly to Vav and ZAP-70, the precipitation of
Nef by Lck SH2 was unaffected by denaturation of ly-
sates in presence of 0.1% SDS followed by boiling but
was inhibited by higher SDS concentrations (Fig. 2A).
The competitive effect of a tyrosine phosphorylated pep-
tide derived from the murine polyomavirus mT antigen
(Y(p)EEI) and known to bind strongly and specifically to
Lck SH2 (Payne et al., 1993) were also examined. A
dose-dependent reduction of binding of both tyrosine
phosphorylated proteins and Nef to Lck SH2 was ob-
served (Fig. 2B).
Most SH2 domain associations are dependent on ty-
rosine-phosphorylated residues (Koch et al., 1991; Straus
et al., 1996). To determine whether the Lck SH2:Nef
interaction was similarly dependent on phosphorylation
events, we performed association assays using phos-
phatase-treated lysates from nef-transfected cells. As
shown in Fig. 3B, phosphatase treatment of cell lysates
abrogated the precipitation of Nef by Lck SH2 and largely
reduced that by Lck SH21SH3 to a level similar to Lck
SH3 precipitation of Nef. The decrease in association
was not due to proteolysis of Nef because the Lck
SH3:Nef interaction was not affected by phosphatase
treatment (Fig. 3B) and equivalent amounts of Nef were
present in all samples followed treatment (not shown).
Similar results were observed with known specific sub-
strates of Lck SH2 (data not shown). The interaction
between Nef and Lck SH2 is thus dependent on phos-
phorylation.
Nef binds Lck SH2 in a phosphotyrosine independent
manner
SIV Nef-mac239 and -pbj14 were found to be phosphory-
lated on tyrosine residues when co-expressed with the
Src tyrosine kinase in COS cells (Du et al., 1995). Simi-
larly, we have previously reported on the weak phosphor-
ylation of HIV-1 NefBRU in transfected lymphoblastoid
Jurkat cells as detected by antiphosphotyrosine Western
blotting of Nef immunoprecipitates (Collette et al., 1996b).
HIV-1BRU Nef protein contains seven tyrosine residues,
although none of these forms a predicted Lck SH2 bind-
ing sequence (Fig. 4A). The solvent accessibility of ty-
rosine side chains was derived from the available crystal
structures of HIV-1 Nef (Lee et al., 1996; Arold et al.,
1997). Tyr81 and Tyr202 are on the surface of the core
domain of Nef, Tyr115, Tyr120, Tyr127, and Tyr135 are partly
exposed, whereas Tyr143 is found buried. To identify
tyrosine(s) residue(s) potentially implicated in Lck SH2:
Nef interaction, we performed site directed mutation of
each tyrosine residues as well as a mutant lacking all
tyrosine residues (DTyr mutant, see Fig. 4A). These con-
struct were verified by DNA sequencing and transferred
in the mammalian expression vector pCDNA3. The ability
of these various mutant proteins to interact with Lck SH2
was examined by transfection of Jurkat cells followed by
FIG. 1—Continued
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precipitation with the Lck recombinant fusion proteins.
Surprisingly, all these mutants, including the DTyr mutant
(Fig. 4B), interacted with Lck SH2. Despite a slightly
reduced level of expression, the DTyr mutant was pre-
cipitated by Lck SH2 with an efficiency similar to Nef wild
type (Fig. 4B). Similar results were obtained using Lck
SH21SH3 (data not shown). Binding of Nef to Lck SH2 is
thus tyrosine independent.
High resolution crystallographic analysis of Src-like SH2
domains complexed with phosphopeptide have revealed
the particular importance of conserved arginine residues
(Arg134 and Arg154 for Lck-SH2) (Eck et al., 1993) in the
phosphotyrosine binding pocket. These arginine residues
provide hydrophobic, electrostatic, hydrogen-bonding, and
amino-aromatic interactions with the phosphotyrosine side
chain (Waksman et al., 1992; Eck et al., 1993). The substi-
tution of these residues with serine and glutamine residue,
respectively, abolishes the high-affinity binding of SH2 do-
mains for phosphotyrosyl proteins (Straus et al., 1996). To
define further the interaction of Nef with Lck SH2, a recom-
binant protein containing a double mutation of these argi-
nine residues (Lck-SH2 R134S-R154Q) was produced in bac-
teria and used to precipitate lysates from pervanadate-
stimulated Jurkat cells. As previously described (Straus et
FIG. 3. Phosphorylation-dependent binding of Nef to Lck SH2.
Jurkat cells were stimulated 5 min at 37°C with 50 mM pervanadate
to increase the level of tyrosine phosphorylated proteins, lysed and
were either left untreated or treated with 3 and 6 unit (U) of potato
acid phosphatase. Lysates were analyzed either directly or following
precipitation by Lck SH2, by antiphosphotyrosine Western blotting
(A). Alternatively, lysates from nef-transfected Jurkat cells were
either left untreated or treated with 6 U of potato acid phosphatase
and precipitated (500 mg of total protein) with the indicated Lck
SH recombinant proteins (20 mg) followed by Nef Western blotting
(B). Total lysates (TL) were included as controls (25 mg of total
protein).
FIG. 2. Comparative analysis of Lck SH2 binding to HIV-1 Nef.
Lysates (500 mg of total protein) from Nef transfected Jurkat cells
were supplemented with 1% SDS followed by boiling. Denatured
lysates were adjusted to 0.1 or 0.5% SDS final using lysis buffer and
processed for GST precipitation (10 mg) followed by Nef, ZAP-70 or
Vav Western blotting (A). Alternatively, cell lysates were added 0, 0.5,
5, or 10 mM of phosphotyrosyl peptide EPQYEEIPI as indicated,
followed by GST precipitation and either Nef or antiphosphotyrosine
Western blotting (B). Total lysates (TL) were included as controls (25
mg of total protein).
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al., 1996), antiphosphotyrosine immunoblotting of these pre-
cipitates revealed that the precipitation of phosphotyrosyl
proteins by Lck SH2 R134S-R154Q was greatly impaired as
compared with Lck SH2 (Fig. 5A). More specifically, Lck
SH2 but not the Lck SH2 R134S-R154Q mutant precipitated
tyrosine phosphorylated ZAP-70 (Fig, 5B). Lysates from nef-
transfected Jurkat cells were similarly analyzed. Strikingly,
anti-Nef immunoblotting revealed that Lck SH2 R134S-R154Q
precipitated Nef as efficiently as Lck SH2 (Fig. 5C). We
conclude that Nef interacts with the Lck SH2 domain in a
novel, phosphotyrosine-independent fashion.
DISCUSSION
We and others have reported previously that the nef
gene product from primate lentiviruses can interact with
FIG. 4. Nef binding does not require Lck SH2 phosphotyrosyl binding pocket. Jurkat cells were stimulated for 5 min. at 37°C with 50 mM
pervanadate and cell lysates were precipitated with 20 mg of Lck SH2 or Lck SH2 R134S-R154Q (see Materials and Methods) followed by
antiphosphotyrosine Western blotting in (A) or ZAP-70 Western blotting in (B). Alternatively, lysates from nef-transfected Jurkat cells were precipitated
(500 mg of total protein) with the indicated Lck SH recombinant protein (20 mg) followed by Nef Western blotting (C). Total lysates (TL) were included
as controls (25 mg of total protein).
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Src family tyrosine kinases (Du et al., 1995; Greenway et
al., 1995; Saksela et al., 1995; Collette et al., 1996b). This
interaction, seen both in vitro (Greenway et al., 1995;
Saksela et al., 1995; Collette et al., 1996b) and in intact
cells (Du et al., 1995; Collette et al., 1996b; Briggs et al.,
1997), results in the modulation of the catalytic activity of
the enzyme (Collette et al., 1996b; Greenway et al., 1996;
Briggs et al., 1997; Moarefi et al., 1997) and can lead to
fibroblast transformation (Du et al., 1995; Briggs et al.,
1997). The precise role of the Src kinases in the viral life
cycle remains to be established, yet a correlation was
noted between Src kinase interaction an viral replication
(Goldsmith et al., 1995; Saksela et al., 1995; Wiskerchen
and Cheng, 1996). A proline motif in Nef is determinant in
these interactions (Saksela et al., 1995; Briggs et al.,
1997) and allows binding to the SH3 domain of Src
kinases, yet with different affinity (Lee et al., 1995; Sak-
sela et al., 1995). In addition to SH3 binding, we also
showed that HIV-1 Nef can interact in a specific manner
with Lck SH2 domain (Collette et al., 1996b), and a
putative SH2-binding motif was identified in SIV Nef (Du
et al., 1995). The present study focused on SH2 binding
by HIV-1 Nef.
We first compared binding of Nef to Lck and Hck
recombinant SH3 and SH2 domains (Fig. 1). A marked
preferences for Hck SH3 binding was observed when
compared with Lck SH3. In a previous report, using Nef
fragments containing the proline motif, only Hck SH3
binding was detected in a filter binding assay with no
detectable binding of Lck SH3 (Saksela et al., 1995).
Here, using the full-length Nef protein expressed in
transfected cells, a low but significant interaction with
Lck SH3 can be detected that is competed by a consen-
sus proline motif peptide and disrupted following muta-
tion of the proline residues 72 and 75 (data not shown).
The higher affinity of Lck SH3 for full-length Nef as
compared with Nef fragments most probably reflects the
role of additional residues of Nef in the interaction with
SH3 domain, as visualized recently by crystallographic
analysis (Lee et al., 1996; Arold et al., 1997). The high-
FIG. 5. Tyrosine residues are not required for binding of Nef to Lck SH2. The HIV-1 Bru/Laı¨ Nef protein contains seven tyrosine residues (Y81, 115,
120, 127, 135, 143, and 200), among which six are present within a conserved region of the protein (A). A Nef mutant with substitution to phenylalanine
of these seven tyrosine residues was constructed (DY). Jurkat cells were mock-transfected or transfected with the wt Nef or the DY constructs followed
by cell lysis, precipitation (500 mg of total protein) by Lck SH2 binding and Nef Western blotting (B). Total lysates (TL) were included as controls (25
mg of total protein).
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affinity binding of Nef to Hck-SH3 is dependent on resi-
due Ile96 present in its RT loop, which is proposed to
contact Nef and to mediate the selective recognition of
Nef by Hck-SH3 (Lee et al., 1995). Lck SH3 has a serine
residue instead of Ile96. One can propose that this resi-
due could explain the weaker affinity of Lck SH3 than
Hck-SH3 for Nef proline-rich region. It is of interest that
in addition to the proline-rich motif, a second binding
motif may stabilize the interaction of Nef to Lck. Similar
cooperation between SH2 and SH3 domains have al-
ready been described (Panchamoorthy et al., 1994). In-
terestingly, the binding of Tip, a Herpes Saimiri product
that associates with Lck, requires at least two Lck bind-
ing motifs (Jung et al., 1995a,b). The first motif is a proline
motif identical to the one identified in Nef (Collette and
Olive, 1997), required for the interaction with Lck SH3 but
is not on its own sufficient for Lck binding. A second
motif has been identified that shares homology with the
C-terminus of Src Kinase (Jung et al., 1995b). This motif,
together with the proline motif allows for Lck binding, yet
through an unknown region. Nef binds Lck SH2 but
neither Hck SH2 (Fig. 1) nor other additional SH2 do-
mains related or not to Src family tyrosine kinases (Col-
lette et al., 1996b), indicating a high degree of specificity
for this interaction.
We next sought to determine the mechanisms of Nef
binding to Lck SH2 and unexpectedly found that it occurs
in a phosphotyrosine independent manner. Our conclu-
sion was drawn from several complementary observa-
tions: (i) SH2 still interacts with the product encoded by
a nef gene with all tyrosines mutated to phenylalanine
residues (Fig. 4); (ii) as compared with tyrosine phos-
phorylated substrates, Lck SH2 binding is only partly
competed by the Y(p)EEI peptide, a highly specific sub-
strate peptide for Src kinase’s SH2 domains (Payne et al.,
1993; Songyang et al., 1993), which fully competed for
Lck SH2 binding of phosphotyrosine substrates (Fig. 2);
and (iii) mutations that completely disrupt the well-de-
fined phosphotyrosine binding pocket within the Lck SH2
domain (Waksman et al., 1992; Eck et al., 1993) do not
alter Nef binding (Fig. 5). Importantly, we made similar
observations using the SIVmac239 nef gene product (H.
Dutartre, unpublished results). These results hence con-
trast to the conventional view of SH2-mediated interac-
tions that involve recognition of the phosphotyrosine
residue in the context of three to five residues carboxyl-
terminal to the tyrosine (Songyang et al., 1993). There is
a growing number of such phosphotyrosine-independent
interactions described in the literature. The BCR (the
Philadelphia chromosome breakpoint cluster region
gene product) was found to bind the SH2 domain from
this translocation partner c-Abl (Pendergast et al., 1991),
as well as to a limited set of SH2 domains (Muller et al.,
1992; Raffel et al., 1996), through phosphotyrosine-inde-
pendent mechanisms. The SH2 domain from the protein-
tyrosine phosphatase SHPTP2 binds its own catalytic
domain in the absence of phosphotyrosine (Dechert et
al., 1994). Even more relevant to the present study, the
SH2 domain from Src tyrosine kinases Src and Fyn was
found to interact with the serine kinase Raf (Cleghon and
Morrison, 1994), and the Lck SH2 domain interacted in a
phosphotyrosyl-independent manner with a recently
cloned ubiquitin-binding protein (Park et al., 1995; Vad-
lamudi et al., 1996) and possibly the tyrosine phospha-
tase CD45 (Ng et al., 1996). In most of these studies, the
conclusion that SH2 binding occurred in a phosphoty-
rosine-independent manner was essentially drawn from
the absence of detectable tyrosine phosphorylation of
the SH2 substrate and/or the lack of tyrosine residue(s)
in the mapped binding region. Here by systematic dis-
ruption of the seven tyrosine residues present in HIV-1-
BRU Nef protein, we formally demonstrate that the Lck
SH2 domain can interact with a viral protein indepen-
dently of tyrosine residues, and hence independently of
tyrosine phosphorylation.
Crystal and solution structures have been determined
for different SH2 domains, both as isolated domain and
in complex with high- or low-affinity peptide substrate
(Booker et al., 1992; Overduin et al., 1992; Waksman et al.,
1992; Eck et al., 1993; Pascal et al., 1994). These studies
have determined the ability of a group of independent
pockets in the SH2 domain to accommodate peptide
side chains. Because binding of Nef to Lck SH2 is partly
competed by the specific Y(p)EEI peptide yet the phos-
photyrosyl binding pocket in the SH2 domain is dispens-
able for this interaction, one can propose that phospho-
tyrosine-independent binding similarly implicates a
group of binding pockets, some of which being shared
by both phosphotyrosine-dependent and -independent
mechanisms. Although tyrosine phosphorylation is not
implicated in binding of Nef to Lck SH2, Pase treatment
reduces the binding of Nef to Lck SH2 and Lck SH213,
demonstrating that phosphorylation events other than
tyrosine phosphorylation regulate this interaction. In the
previously reported cases of phosphotyrosyl-indepen-
dent binding of proteins to SH2 domains, serine phos-
phorylation was suspected to be important (Pendergast
et al., 1991; Cleghon and Morrison, 1994; Malek and
Desiderio, 1994; Raffel et al., 1996). Nef is predominantly
phosphorylated on serine residues in vitro (Bodeus et al.,
1995; Coates and Harris, 1995) and also in vivo (Coates
et al., 1997; Luo et al., 1997), most probably on several
serine residues (Bodeus et al., 1995). Nef can associate
with different serine kinases including the p62 PAK-re-
lated serine kinase (Nunn and Marsh, 1996; Sawai et al.,
1996) and the PKCu isoform (Smith et al., 1996). However,
PKC inhibitors only partially reduce the phosphorylation
of Nef (Coates et al., 1997; Luo et al., 1997), suggesting
that PKC might not be the only kinase responsible of Nef
phosphorylation. Recently, Baur et al. showed an inter-
action of NH2-terminal Nef fragments with a complex
containing Lck and an unidentified serine kinase, pro-
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posed to be implicated in the phosphorylation of Nef
(Baur et al., 1997). The kinase responsible for Nef phos-
phorylation remains to be determined and together with
the identification of Nef phosphorylated serine residues
may provide important tools in the elucidation of the
Nef-Lck SH2 interaction.
The function of the phosphotyrosyl-independent inter-
action of SH2 domains is not well understood, but it is
striking that two viral proteins, Nef and v-Abl, direct such
interactions. It has been suggested that the binding of
Shc to v-Abl SH2 domain (Raffel et al., 1996) might com-
pete for phosphotyrosyl proteins leading to inappropriate
signaling through the Ras pathway. The competition be-
tween Nef and the Y(p)EEI peptide described here (Fig.
2) suggested that a similar signaling alteration following
binding of Nef to Lck SH2 might occur in vivo. Indeed, the
presently described binding of HIV-1 Nef to Lck SH2 and
SH3 domains could represent some viral adaptation to
elude normal protein–protein interaction leading to the
disruption of cellular signaling.
MATERIALS AND METHODS
Plasmids and constructions
The GST Lck SH3, SH2 and SH213 constructs were
previously described (Collette et al., 1996b). The GST Hck
SH3 and SH2 were kind gifts from R. Benarous (ICGM,
Paris), and the Lck GST-SH2 R 134S-R154Q was con-
structed by PCR amplification of the pMNC Lck-R134S-
R154Q plasmid (kindly provided by M. Marsh, London),
using the following oligonucleotides: 59 primer:
59AGTCAGAATTCTGGTTCTTCAAGAATCTGAGC39 con-
taining an EcoRI restriction site and 39 59TCATCAGTC-
GACGCAAGGACGGCTCAACTT39 containing a SalI re-
striction site. The PCR product was purified by gel ex-
traction (Geneclean, Clontech), restricted by EcoRI and
SalI restriction enzyme, and subcloned in pGEX5 vector
(Pharmacia). The construct was verified by sequencing.
The HindIII/XbaI fragment containing the nef gene
from HIV-1 Bru/Laı¨ was subcloned under the transcrip-
tional control of the human CMV IE promoter in the
pcDNA3 vector (INVITROGENE). HIV-1 nefBRU site di-
rected mutagenesis were performed using the Trans-
former Site Directed Mutagenesis Kit (Clontech) accord-
ing to the manufacturer’s instructions. Briefly, the nef
gene contained in the pUC18 backbone as a HindIII-XbaI
fragment was mutated by simultaneous annealing of the
selection primers Trans Oligo NdeI/NcoI or Switch Oligo
NcoI/NdeI provided by the manufacturer (Clontech) and
the mutagenesis primer, which introduces the desired
mutation to one strand of the denatured double-stranded
plasmid. The nef Dtyr was constructed by sequential
mutagenesis of Tyr residues 81, 115, 120, 127 135, 143,
and 202 of HIV-1 nefBRU which were substituted each by
a Phe residue. Introduction of desired substitution and
the integrity of the nef sequence were verified by se-
quencing, followed by subcloning of mutated nef gene in
pCDNA3 vector in the BamHI site.
Cells, cell culture, and transfections
The Jurkat cell clone JH6.2 (20) was cultured in RPMI
supplemented with 10% fetal calf serum (FCS, Gibco-
BRL) and 1 mM L-glutamine.
For transient transfection, 107 of exponentially growing
cells were resuspended in 500 ml of culture medium
containing 20 mg plasmid DNA and electroporated at 250
V and 960 mF using a BIORAD GENE PULSER. Electro-
porated cells were washed once in 10-ml culture me-
dium and cultured further at 37°C, 5% CO2. To increase
the expression of genes placed under the transcriptional
control of the CMV promoter, culture of electroporated
cells were stimulated by PMA (Sigma; 20 to 50 ng/ml or
20 ng/ml) and ionomycin (Sigma; 2 or 1 to 2 mg/ml) for 5
to 16 h at 37°C, as mentioned in figure legends.
Preparation of cell extract
Cells (2.107)/ml were washed once in PBS and lysed in
lysis buffer (1% Triton X-100, 25 mM HEPES pH 7.8, 150
mM NaCl, 10 mM EDTA, 1 mM EGTA supplemented with
1 mM PMSF, 0.1 mM Na Vanadate, 10 mg/ml Leupeptin,
10 mg/ml Aprotinin and Pepstatin). After 15 min on ice,
cell extracts were centrifuged at 4°C for 10 min at 13,000
rpm in a Biofuge and postnuclear supernatants were
collected and used for precipitation.
Precipitation and immunoblotting
The bacterial host Escherichia coli DH5a, transformed
with GST fusion plasmids, was cultured and GST fusion
proteins were purified according to the manufacturer’s
instructions (Pharmacia Biotech Inc.). Briefly, IPTG-in-
duced bacteria cultures were disrupted by sonication,
followed by lysis in Triton-X100 and centrifugation. Solu-
ble proteins were incubated with Glutathione Sepharose
4B to purify GST fusion proteins followed by extensive
washing of the protein complexes. To yield highly puri-
fied GST recombinant proteins, proteins bound to Gluta-
thione Sepharose 4B were eluted with reduced Glutathi-
one followed by protein contents determination by the
Bradford chromogenic method and analysis on a 10%
SDS-PAGE for purity and absence of degradation. The
GST recombinant proteins were either used as soluble
proteins or coupled to Glutathione Sepharose 4B.
Cell extracts were precipitated overnight at 4°C under
agitation with GST fusion protein as indicated in figure
legends. For peptide competition, the (p)YEEI peptide
derived from the Hamster polyomavirus midele T antigen
(kindly provided by O. Acuto, Inst. Pasteur, Paris) was
added to the cell lysate during the precipitation step.
Precipitated proteins were washed three times with 1 ml
of lysis buffer. Bound proteins were eluted with 20 ml 33
Laemmli buffer (Biolabs) and boiling, separated by SDS-
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PAGE, followed by wet-electrotransfer to polyvinyl diflu-
oride membrane in 10 mM CAPS pH 11, 10% Methanol.
Membranes were blocked overnight at 4°C under agita-
tion in 5% non fat milk in TBST buffer (10 mM Tris pH 7.4,
100 mM NaCl and 0.1% Tween 20), or in TBST/5% Bovine
Serum Albumin (BSA, Boehringer) for anti-PTyr immuno-
blotting.
Nef protein was detected using the MATG 0020 mAb
(Transgene, Strasbourg; 1 mg/ml in TBST) followed by a
POD-linked anti-mouse antibody (Dako). After extensive
washing in TBST, bound proteins were detected by
chemiluminescence (ECL, Amersham). ZAP-70, Vav and
phosphotyrosine proteins were similarly detected using
a ZAP-70 rabbit polyclonal antiserum (a kind gift from B.
Malissen, Marseille), a Vav monoclonal antibody (UBI,
Lake Placid) and the monoclonal antibody 4G10 (UBI,
Lake Placid), respectively.
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